These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15967213)

  • 1. Biomarkers to assess potential developmental immunotoxicity in children.
    Luster MI; Johnson VJ; Yucesoy B; Simeonova PP
    Toxicol Appl Pharmacol; 2005 Aug; 206(2):229-36. PubMed ID: 15967213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodologies for developmental immunotoxicity (DIT) testing.
    Dietert RR; Holsapple MP
    Methods; 2007 Jan; 41(1):123-31. PubMed ID: 17161309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental immunotoxicology of lead.
    Dietert RR; Lee JE; Hussain I; Piepenbrink M
    Toxicol Appl Pharmacol; 2004 Jul; 198(2):86-94. PubMed ID: 15236947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role for early-life immune insult including developmental immunotoxicity in chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME).
    Dietert RR; Dietert JM
    Toxicology; 2008 May; 247(1):61-72. PubMed ID: 18336982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune assessments in developmental and juvenile toxicology: practical considerations for the regulatory safety testing of pharmaceuticals.
    Barrow PC; Ravel G
    Regul Toxicol Pharmacol; 2005 Oct; 43(1):35-44. PubMed ID: 16099567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers in aquatic plants: selection and utility.
    Brain RA; Cedergreen N
    Rev Environ Contam Toxicol; 2009; 198():49-109. PubMed ID: 19253039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey: immune function and immunotoxicity assessment in dogs.
    Lebrec H; O'Lone R; Freebern W; Komocsar W; Moore P
    J Immunotoxicol; 2012; 9(1):1-14. PubMed ID: 22059464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing human biologicals in animal host resistance models.
    Burleson GR; Burleson FG
    J Immunotoxicol; 2008 Jan; 5(1):23-31. PubMed ID: 18382855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotoxic effects of chemicals: A matrix for occupational and environmental epidemiological studies.
    Veraldi A; Costantini AS; Bolejack V; Miligi L; Vineis P; van Loveren H
    Am J Ind Med; 2006 Dec; 49(12):1046-55. PubMed ID: 17036363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ICH S8 immunotoxicity guidance. Immune function assessment and toxicological pathology: autonomous or synergistic methods to predict immunotoxicity?
    Spanhaak S
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):373-6. PubMed ID: 16723215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status and burning issues in immunotoxicity testing of drugs.
    van der Laan JW; van Loveren H
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):435-40. PubMed ID: 15982690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pesticide exposure on the human immune system.
    Corsini E; Liesivuori J; Vergieva T; Van Loveren H; Colosio C
    Hum Exp Toxicol; 2008 Sep; 27(9):671-80. PubMed ID: 19042949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent headache as the main symptom of acquired cerebral toxoplasmosis in nonhuman immunodeficiency virus-infected subjects with no lymphadenopathy: the parasite may be responsible for the neurogenic inflammation postulated as a cause of different types of headaches.
    Prandota J
    Am J Ther; 2007; 14(1):63-105. PubMed ID: 17303977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell receptor excision circles (TRECs) analysis during acute intrarectal infection of cynomolgus monkeys with pathogenic chimeric simian human immunodeficiency virus.
    Bona R; Macchia I; Baroncelli S; Negri DR; Leone P; Pavone-Cossut MR; Catone S; Buffa V; Ciccozzi M; Heeney J; Fagrouch Z; Titti F; Cara A
    Virus Res; 2007 Jun; 126(1-2):86-95. PubMed ID: 17336416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hazard identification and risk assessment for biologics targeting the immune system.
    Weir AB
    J Immunotoxicol; 2008 Jan; 5(1):3-10. PubMed ID: 18382852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers and assessment of vaccine responses.
    Hogrefe WR
    Biomarkers; 2005 Nov; 10 Suppl 1():S50-7. PubMed ID: 16298912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune system changes during simulated planetary exploration on Devon Island, high arctic.
    Crucian B; Lee P; Stowe R; Jones J; Effenhauser R; Widen R; Sams C
    BMC Immunol; 2007 May; 8():7. PubMed ID: 17521440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental immunotoxicity (DIT), postnatal immune dysfunction and childhood leukemia.
    Dietert RR
    Blood Cells Mol Dis; 2009; 42(2):108-12. PubMed ID: 19019708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental immunotoxicology: focus on health risks.
    Dietert RR
    Chem Res Toxicol; 2009 Jan; 22(1):17-23. PubMed ID: 18783253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.